BEHANDLUNG DER MIGRÄNE DURCH VERABREICHUNG VON ALPHA-LIPONSÄURE ODER DERIVATEN DERSELBEN

European patent · EP1207878 · Deleted

Register entry

Publication number
EP1207878
Application number
EP00960527
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 26, 2000
Published
May 29, 2002
Granted
Feb 19, 2003
Deleted
Aug 31, 2017
Reason
Annual fee unpaid
IPC classes
A61K 31/385 (2006.01)
A61P 25/06 (2006.01)
Priority
DE 19941217 30.08.1999
PCT application
PCT/EP2000/008315 26.08.2000
PCT publication
WO2001/015693 08.03.2001
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 21, 2018

    Deleted, fee unpaid

    Published in Swissreg on 21.03.2018

  2. Mar 16, 2011

    Address changed

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25 → BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 16.03.2011

  3. Apr 30, 2007

    Agent entered

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in +pat+ No 8 in 2007

  4. Apr 30, 2007

    Address changed

    Owner
    VIATRIS GmbH & Co. KG, Weismüllerstrasse 45, 60314 Frankfurt am Main, Germany → MEDA Pharma GmbH & Co. KG, Benzstrasse 1, 61352 Bad Homburg, Germany

    Published in +pat+ No 8 in 2007

  5. Feb 28, 2003

    Granted

    Published in +pat+ No 4 in 2003

Parties

Inventor

SCHOENEN, Jean

B-4052 Beaufays-Chaudfontaine, BE

ENGEL, Jürgen

63755 Alzenau, DE

WESSEL, Klaus

61118 Bad Vilbel, DE

PEUKERT, Manfred

59581 Warstein, DE

LOBISCH, Michael

61203 Reichelsheim/Blofeld, DE

BORBE, Harald

55127 Mainz, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.